Total Payments
$1,917
2024 Payments
$330.31
Companies
18
Transactions
116
Medicare Patients
82
Medicare Billing
$10,072
Payment Breakdown by Category
Food & Beverage$1,917 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,917 | 116 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $339.92 | 19 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $302.32 | 18 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $289.90 | 18 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $233.98 | 11 | $0 (2023) |
| ABBVIE INC. | $225.53 | 18 | $0 (2024) |
| Alkermes, Inc. | $106.60 | 6 | $0 (2023) |
| Lundbeck LLC | $74.34 | 5 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $57.99 | 3 | $0 (2022) |
| ITI, Inc. | $55.08 | 3 | $0 (2023) |
| Ironshore Pharmaceuticals Inc. | $40.38 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $330.31 | 22 | ABBVIE INC. ($147.62) |
| 2023 | $611.96 | 37 | Teva Pharmaceuticals USA, Inc. ($240.28) |
| 2022 | $273.05 | 17 | Neurocrine Biosciences, Inc. ($54.40) |
| 2021 | $205.21 | 8 | Janssen Pharmaceuticals, Inc ($133.66) |
| 2020 | $83.11 | 5 | Takeda Pharmaceuticals U.S.A., Inc. ($24.59) |
| 2019 | $302.84 | 19 | Janssen Pharmaceuticals, Inc ($84.56) |
| 2018 | $86.22 | 6 | Otsuka America Pharmaceutical, Inc. ($62.37) |
| 2017 | $24.55 | 2 | Otsuka America Pharmaceutical, Inc. ($24.55) |
All Payment Transactions
116 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.56 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $23.72 | General |
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.25 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Neuroscience | ||||||
| 09/11/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $15.26 | General |
| 09/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: PSYCHIATRY | ||||||
| 08/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: NEUROSCIENCE | ||||||
| 06/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.19 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Neurology | ||||||
| 04/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.14 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: PSYCHIATRY | ||||||
| 03/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: PSYCHIATRY | ||||||
| 01/24/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Neurology | ||||||
| 12/13/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Neuropsychiatry | ||||||
| 12/12/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $29.53 | General |
| Category: Central Nervous System | ||||||
| 12/07/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 14 | 26 | $5,200 | $1,496 |
| 2022 | 2 | 36 | 61 | $9,159 | $4,114 |
| 2021 | 2 | 32 | 60 | $5,846 | $4,463 |
Total Patients
82
Total Services
147
Medicare Billing
$10,072
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 26 | $5,200 | $1,496 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 29 | $5,109 | $2,212 | 43.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 32 | $4,051 | $1,902 | 46.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 27 | $3,130 | $2,264 | 72.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 33 | $2,716 | $2,198 | 80.9% |
About Dr. Daniel Ulrich, MD
Dr. Daniel Ulrich, MD is a Child & Adolescent Psychiatry healthcare provider based in Kirksville, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1508075698.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Ulrich, MD has received a total of $1,917 in payments from pharmaceutical and medical device companies, with $330.31 received in 2024. These payments were reported across 116 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,917).
As a Medicare-enrolled provider, Ulrich has provided services to 82 Medicare beneficiaries, totaling 147 services with total Medicare billing of $10,072. Data is available for 3 years (2021–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Child & Adolescent Psychiatry
- Other Specialties Pediatrics, Psychiatry
- Location Kirksville, MO
- Active Since 05/22/2007
- Last Updated 09/15/2025
- Taxonomy Code 2084P0804X
- Entity Type Individual
- NPI Number 1508075698
Products in Payments
- VRAYLAR (Drug) $237.79
- INGREZZA (Drug) $233.98
- SPRAVATO (Drug) $208.64
- ABILIFY MAINTENA (Drug) $198.77
- REXULTI (Drug) $186.89
- Austedo XR (Drug) $112.42
- UZEDY (Drug) $94.12
- ARISTADA (Drug) $93.74
- INVEGA SUSTENNA (Drug) $93.68
- AUSTEDO (Drug) $83.36
- CAPLYTA (Drug) $55.08
- TRINTELLIX (Drug) $41.15
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $40.38
- Auvelity (Drug) $38.14
- QELBREE (Drug) $30.39
- BRINTELLIX (Drug) $28.60
- Epclusa (Drug) $18.02
- Trintellix (Drug) $16.84
- LATUDA (Drug) $14.15
- LYBALVI (Drug) $12.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.